Effect of combined topical heparin and steroid on corneal neovascularization in children

Rike Michels1, Stephan Michels, Stephan Kaminski

  • 1Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland.

Insights

Topical heparin and steroid eye drops effectively treat corneal neovascularization (CN) in children, leading to rapid regression. This combination therapy is safe and well-tolerated, offering a promising option for pediatric eye conditions.

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology
  • Angiogenesis Research

Background:

  • Corneal neovascularization (CN) poses a significant risk for vision loss in children.
  • Limited effective therapeutic options exist for pediatric CN.
  • Amblyopia is a common complication associated with CN, especially with optical axis involvement.

Observation:

  • A combination therapy of topical heparin and a steroid (rimexolone or dexamethasone) was administered to five eyes across four children with progressive CN.
  • Treatment involved daily topical application until complete regression of CN was achieved.
  • Regression was monitored using slit-lamp examinations and anterior segment photography.

Findings:

  • Complete regression of CN was observed in all five treated eyes within five months.
  • An anti-angiogenic effect was evident as early as one week into treatment.
  • The combination therapy demonstrated a favorable safety profile, with no ocular or systemic side effects reported.
  • Recurrence occurred in two eyes post-treatment but responded well to re-treatment.

Implications:

  • Topical heparin and steroid combination therapy offers a rapid and effective treatment for pediatric corneal neovascularization.
  • This approach is particularly valuable for children with limited treatment alternatives and high amblyopia risk.
  • The findings support the use of this combination as a promising therapeutic strategy in pediatric ophthalmology.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...